8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Efficacy of oral lycopene in the treatment of oral leukoplakia.

      Oral Oncology

      Administration, Oral, Adolescent, Adult, Aged, Aged, 80 and over, Anticarcinogenic Agents, administration & dosage, Carotenoids, Child, Drug Administration Schedule, Female, Humans, Leukoplakia, Oral, drug therapy, pathology, Male, Middle Aged, Treatment Outcome

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study evaluates the efficacy of lycopene in the treatment of oral leukoplakia and compares two different doses with a placebo. Fifty-eight clinically and histologically diagnosed patients of oral leukoplakia were selected for the study. They were randomly divided into three groups. Group A: (n = 20; 8 mg lycopene/day), Group B: (n = 20; 4 mg lycopene/day) and Group C: (n = 18; placebo). The duration of the therapy was three months. Outcome was assessed clinically as well as histologically. Post-treatment patients were on follow-up for two months. Student's 't' test was used for statistical evaluation. Clinically the patients in Groups A, B, C had a mean response of 80%, 66.25% and 12.5% respectively. Histological evaluation too had similar results. Patients receiving lycopene in both regimes show highly significant difference in response as compared to placebo (Group C). The observed effect of lycopene suggests that it can be effectively and safely used for the management of oral leukoplakia.

          Related collections

          Author and article information

          Journal
          15063387
          10.1016/j.oraloncology.2003.12.011

          Comments

          Comment on this article